Ricardo Hernandez-Castillo
Pulmonary Disease · San Juan, PRNPI 1629392527
Payments from drug & device makers
Across 53 payments — averaging $32.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$590
- AstraZeneca$198
- GSK$154
- Johnson & Johnson$137
- Boehringer Ingelheim$130
- Genentech USA, Inc.$115
- plus $380 from 12 others
What the payments were for
- Travel & lodging$45627%
- Food & beverage$1,24773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 4 | $590 |
| AstraZeneca | 6 | $198 |
| GSK | 7 | $154 |
| Johnson & Johnson | 6 | $137 |
| Boehringer Ingelheim | 6 | $130 |
| Genentech USA, Inc. | 6 | $115 |
| Sanofi | 3 | $62 |
| United Therapeutics Corporation | 2 | $45 |
| Pfizer | 2 | $45 |
| Bayer | 2 | $38 |
| PBG Puerto Rico LLC | 2 | $33 |
| Olympus Latin America, Inc. | 1 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $26 |
| Eli Lilly Export S.A. Puerto Rico Branch | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| AbbVie | 1 | $17 |
| Mylan LLC | 1 | $16 |
| Chiesi USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,703 in reported general payments places this provider in the 35th percentile of 138 pulmonary disease providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in San Juan
- Edgardo Cartagena AyalaSan Juan$1M
- Ramon FloresSan Juan$86K
- Joel Nieves ScharonSan Juan$55K
- William RodriguezSan Juan$15K
- Luis Gerena MontanoSan Juan$15K
- Rafael Franjul JuliaoSan Juan$15K
- Roberto Martinez QuintanaSan Juan$12K
- Sandra Rosario LebronSan Juan$11K
- Juan Malpica-SantiagoSan Juan$11K
- Daphne Delgado PerezSan Juan$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.